Rare diseases
Investigational molecules
Locations
Turnhoutseweg 30, 2340 Beerse, Belgium
Multiple myeloma, relapsed or refractory myeloma, chronic lymphocytic leukemia, small lymphocytic lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia, myelodysplastic neoplasms, and AL amyloidosis are prominent areas of interest, alongside studies in mantle cell lymphoma and other B-cell malignancies.
Research also extends to warm autoimmune hemolytic anemia and other haematology-focused conditions.
Janssen Cilag International runs clinical trials in conditions such as Plasma cell myeloma, Non-small cell lung cancer, Crohn's disease, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of icotrokinra for adults with moderately to severely active Crohn's disease
BelgiumPhase 1 Study of JNJ-95804306 in Adults with Relapsed or Refractory AML, Higher‑Risk MDS, CLL and SLL
BelgiumStudy of Amivantamab, Lazertinib, and Pemetrexed for Patients with Advanced or Metastatic Solid Tumors, Including EGFR-Mutated Non-Small Cell Lung Cancer
FranceRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
CzechiaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
AustriaPhase 2 Neoadjuvant Study of Amivantamab with Lazertinib in Resectable EGFR‑Mutated Non‑Small Cell Lung Cancer Patients
SpainPhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
CzechiaA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
AustriaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis
AustriaA Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
AustriaA Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
